Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/1998
03/04/1998CN1174711A Medicinal preparation for purpura
03/04/1998CN1174705A Medical preparation cantaining anti hemolytic blood-fat material
03/03/1998US5723606 Condensed benzazepine derivative and pharmaceutical composition thereof
03/03/1998US5723576 Polypeptides for enzyme inhibitors and hirundin
03/03/1998US5723480 Adhesion receptor antagonists III
03/03/1998US5723444 Enzyme inhibitors and anticoagulants
03/03/1998US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity
03/03/1998US5723281 Plasma-like substance
03/03/1998US5723123 Process for the production of a virus-free concentrate of thrombin
03/03/1998US5723122 Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases
02/1998
02/28/1998CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods
02/26/1998WO1998007855A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007725A1 Purine derivatives and their use as anti-coagulants
02/26/1998WO1998007723A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
02/26/1998WO1998007696A1 Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds
02/26/1998WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/26/1998WO1997038966A3 Cytoprotective compounds
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/26/1998CA2263192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2262876A1 Purine derivatives and their use as anti-coagulants
02/26/1998CA2261908A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
02/25/1998EP0825184A1 Heterocyclic derivatives as platelet aggregation inhibitors
02/25/1998EP0825180A1 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives, process for producing the same, and medicinal composition containing the same
02/25/1998EP0824515A1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them
02/25/1998CN1174054A Medicine for removing thrombus and promoting blood circulation and its preparation
02/24/1998US5721366 Phenylamidine derivatives
02/24/1998US5721253 Fibrinogen receptor antagonists
02/24/1998US5721249 Administering to treat angina
02/24/1998US5721238 2,8-disubstituted quinazolinones
02/24/1998US5721222 Inhibitors of human leukocyte elastase
02/24/1998US5721219 N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation
02/24/1998US5720956 Method of controlling the reactivity of human blood platelets by oral administration of the extract of the maritime pine (pycnogenol)
02/24/1998CA2002208C Extraction methods for preparing thromboplastin reagents
02/19/1998WO1998006849A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
02/19/1998WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12)
02/19/1998WO1998006747A2 Uses for wnt polypeptides
02/19/1998WO1998006743A1 Acylated peptide cytolytic peptide inhibitors
02/19/1998WO1998006741A1 Thrombin inhibitors
02/19/1998WO1998006740A1 Dipeptide benzamidine as a kininogenase inhibitor
02/19/1998WO1998006707A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists
02/19/1998WO1998006701A1 Il-8 receptor antagonists
02/19/1998WO1998006694A1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
02/19/1998WO1998006437A2 Compositions and methods for polynucleotide delivery
02/19/1998WO1998006400A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
02/19/1998WO1998006399A1 Il-8 receptor antagonists
02/19/1998WO1998006397A1 Il-8 receptor antagonists
02/19/1998WO1998006396A1 Thrombin inhibitors
02/19/1998WO1998006262A1 Il-8 receptor antagonists
02/19/1998WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins
02/19/1998DE19632773A1 Neue Thrombininhibitoren New thrombin inhibitors
02/19/1998DE19632772A1 Neue Benzamidine New benzamidines
02/19/1998CA2263789A1 Acylated peptide cytolytic peptide inhibitors
02/19/1998CA2263388A1 Il-8 receptor antagonists
02/19/1998CA2263344A1 Dipeptide benzamidine as a kininogenase inhibitor
02/19/1998CA2263311A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists
02/19/1998CA2263220A1 Thrombin inhibitors
02/19/1998CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
02/19/1998CA2262686A1 Thrombin inhibitors
02/19/1998CA2262507A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
02/19/1998CA2262117A1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
02/18/1998CN1173872A Thrombin inhibitors
02/18/1998CN1173821A Methods of inhibiting cell-cell adhesion
02/17/1998US5719278 Tricyclic benzazepine vasopressin antagonists
02/17/1998US5719162 Fibrinogen receptor antagonists
02/17/1998US5719144 Fibrinogen receptor antagonists
02/17/1998US5719138 Contacting with a dicitrate cyclic diester
02/17/1998US5719128 Factor IIa inhibitors
02/17/1998US5719041 DNA encoding ecotin homologs
02/17/1998CA1339678C Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease
02/12/1998WO1998005779A1 Modified tie-2-receptor ligands
02/12/1998WO1998005776A2 Secreted proteins and polynucleotides encoding them
02/12/1998WO1998005317A1 Il-8 receptor antagonists
02/12/1998CA2262399A1 Secreted proteins and polynucleotides encoding them
02/11/1998EP0823476A2 Method for activating prothrombin to thrombin
02/11/1998EP0822934A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
02/11/1998EP0822932A1 Piperidine derivatives as diuretic
02/11/1998EP0714407B1 Composition and methods using nitroxides to avoid oxygen toxicity
02/11/1998EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy
02/11/1998EP0500734B1 Protein complexes having factor viii:c activity and production thereof
02/11/1998CN1173136A Method for stimulating erythropoiesis using hematopoietic proteins
02/11/1998CN1172591A Dietetic foods and pharmaceutical preparations inhibiting blood coagulation
02/10/1998US5716970 Diuretic compound
02/10/1998US5716955 Cytokine inhibitor
02/10/1998US5716951 Tricyclic inhibitors of the vitronectin receptor
02/10/1998US5716934 Eck receptor ligands
02/10/1998US5716644 Lyophilized solution containing erythropoietin, ammonium sulfate, ph 5-7 buffer
02/10/1998US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments
02/10/1998CA1339663C 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivate, processfor producingthem and use thereof
02/10/1998CA1339661C Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines
02/05/1998WO1998004693A2 Secreted proteins and polynucleotides encoding them
02/05/1998WO1998004686A2 Pro-protein converting enzyme
02/05/1998WO1998004259A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR
02/05/1998WO1997040069A3 Secreted proteins and polynucleotides encoding them
02/05/1998CA2289699A1 Secreted proteins and polynucleotides encoding them
02/04/1998EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation.
02/04/1998EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/04/1998EP0821728A1 Tie-2 ligands, methods of making and uses thereof
02/04/1998EP0821685A1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
02/04/1998EP0506821B1 Hybrid protein c
02/04/1998CN1172485A Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same